# Oxford Nanopore Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxford-nanopore-technologies

- Industry: Biotechnology
- Headquarters: Oxford, UK
- Website: www.nanoporetech.com
- Total disclosed funding: $79M
- Latest round: Series D (May 6, 2011)
- Investors on record: 5

## About

Based in Oxford, US, and founded in 2005 by co-founders Gordon Sanghera and Hagan Bayley, Oxford Nanopore Technologies Ltd. is a biotechnology company that focuses on producing nanopore sequencing products. In July 2015, the company published on nanopore sequencing of an influenza genome. The Company announced a chemical update to ‘R9' in March 2016, employing the protein nanopore CsgG in cooperation with Han Remaut's group (VIB/Vrije Universiteit Brussel), and the R9 nanopore was released in late May 2016. GridION was commercially released in 2017 and PromethION in 2018, with the device, the PromethION 48, started shipping in 2019. Flongle, a MinION/GridION adaptor was released in 2019. The company in 2021 has over 1,400 patents and patent applications spread over 200 patent families. The company as of 2021 has raised a total of 17 funding rounds including its funding in May 2021 for GBP 195 million in pre-IPO funding.

The company's nanopore sequencing products include Minion, Gridion, Flongle, and Promethion, which are used to sequence and analyze biological samples, Voltrax, which is designed as an alternative to a variety of lab equipment, allowing the preparation of biological samples ready for analysis, sequencing kits, and flow cells. In development are Promethion p2, Smidgion, and Plongle, which employ nanopore technology. The company's products are utilized for DNA sequencing, RNA and gene expression analysis, and future protein analysis technologies.

The company generates revenue from the sale of products, rendering services, and lease income.

Oxford Nanopore Technologies has plans to get listed on the London stock market in the second half of 2021. The company also plans to purchase 150 million pounds of additional shares at Nanopore's forthcoming IPO in London.

## Funding rounds

- Series D, May 6, 2011, $41M — Longview Innovation, Invesco Perpetual, Illumina, Inc., Redmile Group, Lansdowne Partners
- Series C, Feb 11, 2010, $27M — Longview Innovation, Invesco Perpetual, Illumina, Inc., Lansdowne Partners
- Series B, May 1, 2006, $10M — Longview Innovation

## Investors

- Longview Innovation (https://capitalatlas.ai/funds/longview-innovation) — Series B, Series C, Series D
- Invesco Perpetual — Series C, Series D
- Illumina, Inc. — Series C, Series D
- Lansdowne Partners (https://capitalatlas.ai/funds/lansdowne-partners) — Series C, Series D
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series D